Telomeres and prognosis in patients with chronic lymphocytic leukaemia

International Journal of Hematology

Volumn 93, Issue 1, 2011, Pages 74-82

  Sellmann, Ludger ^a   De Beer, Dirk ^b   Bartels, Marius ^a   Opalka, Bertram ^a   Nückel, Holger ^a   Dührsen, Ulrich ^a   Dürig, Jan ^a   Seifert, Marc ^a   Siemer, Dörte ^a   Küppers, Ralf ^a   Baerlocher, Gabriela M ^b,c   Röth, Alexander ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

CLL; IGHV mutations; Prognostic factors; Telomerase; Telomeres

Indexed keywords

TELOMERASE;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; DELTA TELOMERE LENGTH; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; TELOMERE;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MUTATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TELOMERE;

EID: 78751580313     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0750-2     Document Type: Article

References (40)

1. N Chiorazzi KR Rai M Ferrarini 2005 Chronic lymphocytic leukemia N Engl J Med 352 804 815 1:CAS:528:DC%2BD2MXhsFCiu74%3D 10.1056/NEJMra041720 15728813
2. TJ Kipps 2000 Chronic lymphocytic leukemia Curr Opin Hematol 7 223 234 1:STN:280:DC%2BD3M%2FjtVGmug%3D%3D 10.1097/00062752-200007000-00005 10882178
3. T Seiler H Döhner S Stilgenbauer 2006 Risk stratification in chronic lymphocytic leukemia Semin Oncol 33 186 194 1:CAS:528:DC%2BD28XkvVahsLo%3D 10.1053/j.seminoncol.2006.01.017 16616065
4. JL Binet F Caligaris-Cappio D Catovsky B Cheson T Davis G Dighiero, et al. 2006 Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia Blood 107 859 861 1:CAS:528:DC%2BD28Xht1OnsLs%3D 10.1182/blood-2005-04-1677 16223776
5. RN Damle T Wasil F Fais F Ghiotto A Valetto SL Allen, et al. 1999 Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood 94 1840 1847 1:CAS:528:DyaK1MXlvFCnur0%3D 10477712
6. TJ Hamblin Z Davis A Gardiner DG Oscier FK Stevenson 1999 Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia Blood 94 1848 1854 1:CAS:528:DyaK1MXlvFCnuro%3D 10477713
7. A Kröber T Seiler A Benner L Bullinger E Bruckle P Lichter, et al. 2002 V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia Blood 100 1410 1416 12149225
8. M Crespo F Bosch N Villamor B Bellosillo D Colomer M Rozman, et al. 2003 ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia N Engl J Med 348 1764 1775 1:CAS:528: DC%2BD3sXjtlWqsro%3D 10.1056/NEJMoa023143 12724482
9. S Stilgenbauer L Bullinger P Lichter H Döhner 2002 Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course Leukemia. 16 993 1007 1:CAS:528: DC%2BD38XksFOnu7Y%3D 10.1038/sj.leu.2402537 12040431
10. H Döhner S Stilgenbauer K Döhner M Bentz P Lichter 1999 Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis J Mol Med 77 266 281 10.1007/s001090050350 10023780
11. Verfaillie CM, Pera MF, Lansdorp PM. Stem cells: hype and reality. Hematol Am Soc Hematol Educ Program. 2002;1:369-91.
12. CB Harley AB Futcher CW Greider 1990 Telomeres shorten during ageing of human fibroblasts Nature 345 458 460 1:CAS:528:DyaK3cXksFKntb4%3D 10.1038/345458a0 2342578
13. GB Morin 1989 The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats Cell 59 521 529 1:CAS:528:DyaK3cXpsVeiuw%3D%3D 10.1016/0092-8674(89)90035-4 2805070
14. JC Poole LG Andrews TO Tollefsbol 2001 Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT) Gene. 269 1 12 1:CAS:528:DC%2BD3MXjs1yqsbk%3D 10.1016/S0378-1119(01)00440-1 11376932
15. N Hug J Lingner 2006 Telomere length homeostasis Chromosoma 115 413 425 1:CAS:528:DC%2BD28XhtFegt7bO 10.1007/s00412-006-0067-3 16741708
16. M Engelhardt UM Martens 1998 The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (review) Oncol Rep 5 1043 1052 1:CAS:528:DyaK1cXls1Kmsb4%3D 9683806
17. NP Weng LD Palmer BL Levine HC Lane CH June RJ Hodes 1997 Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging Immunol Rev 160 43 54 1:CAS:528:DyaK1cXlvVSmsQ%3D%3D 10.1111/j.1600-065X.1997.tb01026.x 9476664
18. M Hultdin E Gronlund KF Norrback T Just K Taneja G Roos 2001 Replication timing of human telomeric DNA and other repetitive sequences analyzed by fluorescence in situ hybridization and flow cytometry Exp Cell Res 271 223 229 1:CAS:528:DC%2BD3MXosFGhsLY%3D 10.1006/excr.2001.5391 11716534
19. U Klein Y Tu GA Stolovitzky M Mattioli G Cattoretti H Husson, et al. 2001 Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells J Exp Med 194 1625 1638 1:CAS:528:DC%2BD3MXovVOkt7c%3D 10.1084/jem.194.11.1625 11733577
20. N Chiorazzi M Ferrarini 2003 B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor Annu Rev Immunol 21 841 894 1:CAS:528:DC%2BD3sXjtF2isL4%3D 10.1146/annurev.immunol.21.120601.141018 12615894
21. M Fischer U Klein R Kuppers 1997 Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation J Clin Invest 100 1667 1676 1:CAS:528:DyaK2sXmsFeiurw%3D 10.1172/JCI119691 9312164
22. D Poncet A Belleville RC de t'kint CA de Roborel SE Ben H Merle-Beral, et al. 2008 Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia Blood 111 2388 2391 1:CAS:528:DC%2BD1cXisVeitb8%3D 10.1182/blood-2007-09-111245 18077792
23. M Hultdin R Rosenquist U Thunberg G Tobin KF Norrback A Johnson, et al. 2003 Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications Br J Cancer 88 593 598 1:CAS:528:DC%2BD3sXht1Glu74%3D 10.1038/sj.bjc.6600763 12592375
24. P Grabowski M Hultdin K Karlsson G Tobin A Aleskog U Thunberg, et al. 2005 Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status Blood 105 4807 4812 1:CAS:528:DC%2BD2MXlsVWisro%3D 10.1182/blood-2004-11-4394 15746080
25. RN Damle FM Batliwalla F Ghiotto A Valetto E Albesiano C Sison, et al. 2004 Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations Blood 103 375 382 1:CAS:528:DC%2BD2cXmsFertA%3D%3D 10.1182/blood-2003-04-1345 14504108
26. OE Bechter W Eisterer G Pall W Hilbe T Kuhr J Thaler 1998 Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia Cancer Res 58 4918 4922 1:CAS:528:DyaK1cXnt1yisLw%3D 9810000
27. G Roos A Krober P Grabowski D Kienle A Buhler H Dohner, et al. 2008 Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia Blood 111 2246 2252 1:CAS:528:DC%2BD1cXisVeit70%3D 10.1182/blood-2007-05-092759 18045969
28. BD Cheson JM Bennett M Grever N Kay MJ Keating S O'Brien, et al. 1996 National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment Blood 87 4990 4997 1:CAS:528:DyaK28XjsFGisb8%3D 8652811
29. UH Frey H Nückel L Sellmann D Siemer R Küppers J Dürig, et al. 2006 The GNAS1 T393C Polymorphism is associated with disease progression and survival in Chronic Lymphocytic Leukemia Clin Cancer Res 12 5686 5692 1:CAS:528:DC%2BD28XhtVartbrK 10.1158/1078-0432.CCR-06-0288 17020971
30. R Schroers F Griesinger L Trümper D Haase B Kulle L Klein-Hitpass, et al. 2005 Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia Leukemia. 19 750 758 1:CAS:528:DC%2BD2MXjsFOktLc%3D 10.1038/sj.leu.2403707 15759031
31. H Döhner S Stilgenbauer A Benner E Leupolt A Krober L Bullinger, et al. 2000 Genomic aberrations and survival in chronic lymphocytic leukemia N Engl J Med 343 1910 1916 10.1056/NEJM200012283432602 11136261
32. H Yamaguchi GM Baerlocher PM Lansdorp SJ Chanock O Nunez E Sloand, et al. 2003 Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome Blood 102 916 918 1:CAS:528:DC%2BD3sXlvFCmsbk%3D 10.1182/blood-2003-01-0335 12676774
33. GM Baerlocher I Vulto G de Jong PM Lansdorp 2006 Flow cytometry and FISH to measure the average length of telomeres (flow FISH) Nat Protoc 1 2365 2376 1:CAS:528:DC%2BD2sXhtFGjtLbL 10.1038/nprot.2006.263 17406480
34. A Röth D de Beer H Nückel L Sellmann U Dührsen J Dürig, et al. 2008 Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemia Br J Haematol 143 383 386 10.1111/j.1365-2141.2008.07363.x 18759763
35. D Rossi BC Lobetti E Genuardi L Monitillo D Drandi M Cerri, et al. 2009 Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia Leukemia. 218 122 130
36. SH Walsh P Grabowski M Berglund U Thunberg M Thorselius G Tobin, et al. 2007 Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas Eur J Haematol 78 283 289 1:CAS:528:DC%2BD2sXkvFehu7s%3D 10.1111/j.1600-0609.2007.00817.x 17286609
37. I Ricca A Rocci D Drandi R Francese M Compagno BC Lobetti, et al. 2007 Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients Leukemia. 21 697 705 1:CAS:528:DC%2BD2sXjt1Wktb4%3D 17301820
38. S Palanduz N Serakinci K Cefle M Aktan G Tutkan S Ozturk, et al. 2006 A different approach to telomere analysis with ddPRINS in chronic lymphocytic leukemia Eur J Med Genet. 49 63 69 10.1016/j.ejmg.2005.01.023 16473311
39. A Röth J Dürig H Himmelreich S Bug R Siebert U Dührsen, et al. 2007 Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia Leukemia. 21 2456 2462 10.1038/sj.leu.2404968 17898784
40. A Röth CB Harley GM Baerlocher 2010 Imetelstat (GRN163L)-telomerase- based cancer therapy Recent Results Cancer Res 184 221 234 10.1007/978-3-642- 01222-8-16 20072842